At these prices, this company are going to bought out by a foreign entity. Perhaps they will offer 20% premium for the company and make a bucket load after that.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025